Unraveling the Impact of Thalidomide at Diverse Doses in Transfusion Dependent Beta Thalassemia

Clinical trial NCT06490627 · RECRUITING

Trial details

NCT number: NCT06490627
Sponsor: National Institute of Blood and Marrow Transplant (NIBMT), Pakistan
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Fetal Hemoglobin Thalassemia Major Genetic Disease

Start date: 2024-04-22
Primary completion: 2025-04-22
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.